source
- EU officials outline major pharmaceutical legislative reforms at RAPS Convergence 2026At RAPS Convergence 2026 in Charlotte, North Carolina, officials from the European Commission and the European Medicines Agency presented a set of reforms aimed at overhauling the European Union’s…
- Bristol Myers ends $100M Phase 1 cancer ADC programBristol Myers Squibb announced it has discontinued development of its Phase 1 antibody-drug conjugate candidate BMS-986497/ORM-6151. The decision follows a review of early clinical data, leading t…